Evidence map›Paper›PMID 38289789›Full record

ArticleThe journals of gerontology. Series A, Biological sciences and medical sciences2024

Meeting Summary of The NYO3 5th NO-Age/AD Meeting and the 1st Norway-UK Joint Meeting on Aging and Dementia: Recent Progress on the Mechanisms and Interventional Strategies.

He-Ling Wang, Richard Siow, Tomas Schmauck-Medina, Jianying Zhang, Per Morten Sandset, Clare Filshie, Øystein Lund, Linda Partridge, Linda Hildegard Bergersen, Lene Juel Rasmussen and 28 more

Open access · hybridAbstract read
In one paragraph

Article in The journals of gerontology. Series A, Biological sciences and medical sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 20 institutions in 13 countries.

He-Ling WangDepartment of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, Lørenskog, Norway.ORCID 0000-0002-8920-1487
Richard SiowSchool of Cardiovascular and Metabolic Medicine & Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.
Tomas Schmauck-MedinaDepartment of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, Lørenskog, Norway.
Jianying ZhangDepartment of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, Lørenskog, Norway.
Per Morten SandsetDepartment of Haematology, Oslo University Hospital, Oslo, Norway.
Clare FilshieBritish Embassy Oslo, Oslo, Norway.
Øystein LundRoyal Norwegian Embassy in London, London, UK.
Linda PartridgeMax Planck Institute for Biology of Ageing, Cologne, Germany.
Linda Hildegard BergersenBrain and Muscle Energy Group, Institute of Oral Biology, University of Oslo, Oslo, Norway.
Lene Juel RasmussenDepartment of Cellular and Molecular Medicine, Center for Healthy Aging, University of Copenhagen, Copenhagen, Denmark.
Konstantinos PalikarasDepartment of Physiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Ioannis SotiropoulosInstitute of Biosciences and Applications NCSR "Demokritos," Athens, Greece.
Jon Storm-MathisenDivision of Anatomy, Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
David C RubinszteinDepartment of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.
Maria Grazia SpillantiniDepartment of Clinical Neuroscience, University of Cambridge, Cambridge, UK.
Chris I De ZeeuwNetherlands Institute for Neuroscience, Amsterdam, The Netherlands.
Leiv Otto WatneInstitute of Clinical Medicine, Campus Ahus, University of Oslo, Oslo, Norway.
Martin VyhnalekInternational Clinical Research Centre, St. Anne's University Hospital, Brno, Czech Republic.
Katerina VeverovaDepartment of Neurology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.
Kristina Xiao LiangDepartment of Clinical Medicine, University of Bergen, Bergen, Norway.
Nektarios TavernarakisInstitute of Molecular Biology and Biotechnology Foundation for Research and Technology, Heraklion, Greece.
Vilhelm A BohrDepartment of Cellular and Molecular Medicine, Center for Healthy Aging, University of Copenhagen, Copenhagen, Denmark.
Koutaro YokoteDepartment of Endocrinology, Hematology, and Gerontology, Chiba University Graduate School of Medicine, Chiba, Japan.
Janna SaarelaCentre for Molecular Medicine Norway (NCMM), University of Oslo, Oslo, Norway.
Hilde NilsenDepartment of Microbiology, Oslo University Hospital, Oslo, Norway.ORCID 0000-0003-2115-2663
Efstathios S GonosNational Helenic Research Foundation, Institute of Biology, Medicinal Chemistry and Biotechnology, Athens, Greece.
Morten Scheibye-KnudsenDepartment of Cellular and Molecular Medicine, Center for Healthy Aging, University of Copenhagen, Copenhagen, Denmark.
Guobing ChenGuangdong-Hong Kong-Macau Great Bay Area Geroscience Joint Laboratory, Guangzhou, China.ORCID 0000-0002-2401-6168
Hisaya KatoDepartment of Endocrinology, Hematology, and Gerontology, Chiba University Graduate School of Medicine, Chiba, Japan.
Geir SelbækInstitute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Tormod FladbyInstitute of Clinical Medicine, Campus Ahus, University of Oslo, Oslo, Norway.
Per NilssonDepartment of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden.
Anne SimonsenDepartment of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Dag AarslandCentre for Age-Related Medicine, Stavanger University Hospital, Stavanger, Norway.
Sofie LautrupDepartment of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, Lørenskog, Norway.ORCID 0000-0002-6632-7853
Ole Petter OttersenCentre for Sustainable Healthcare Education, Faculty of Medicine, University of Oslo, Oslo, Norway.
Lynne S CoxDepartment of Biochemistry, University of Oxford, Oxford, UK.
Evandro F FangDepartment of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, Lørenskog, Norway.
University of Oslo · NOUniversity of Copenhagen · DKOslo University Hospital · NOCharles University · CZChiba University · JPKing's College London · GBUniversity of Cambridge · GBCentral South University · CNJinan University · CNKarolinska Institutet · SEMRC Unit for Lifelong Health and Ageing · GBNational and Kapodistrian University of Athens · GRNational Centre of Scientific Research "Demokritos" · GRNational Hellenic Research Foundation · GRNetherlands Institute for Neuroscience · NLRoyal Norwegian Embassy in London · GBUniversity of Bergen · NOUniversity of Crete · GRUniversity of Helsinki · FIUniversity of Oxford · GB

Funding

Alzheimer's SocietyWellcome Trust
6 · The paper itself

Abstract

Unhealthy aging poses a global challenge with profound healthcare and socioeconomic implications. Slowing down the aging process offers a promising approach to reduce the burden of a number of age-related diseases, such as dementia, and promoting healthy longevity in the old population. In response to the challenge of the aging population and with a view to the future, Norway and the United Kingdom are fostering collaborations, supported by a "Money Follows Cooperation agreement" between the 2 nations. The inaugural Norway-UK joint meeting on aging and dementia gathered leading experts on aging and dementia from the 2 nations to share their latest discoveries in related fields. Since aging is an international challenge, and to foster collaborations, we also invited leading scholars from 11 additional countries to join this event. This report provides a summary of the conference, highlighting recent progress on molecular aging mechanisms, genetic risk factors, DNA damage and repair, mitophagy, autophagy, as well as progress on a series of clinical trials (eg, using NAD+ precursors). The meeting facilitated dialogue among policymakers, administrative leaders, researchers, and clinical experts, aiming to promote international research collaborations and to translate findings into clinical applications and interventions to advance healthy aging.

Indexed as

AgingDementiaAgedHumansLongevityNorwayUnited KingdomAgingAlzheimer’s diseaseDementiaLongevityNeurodegeneration

Identifiers

PMID38289789
PMCPMC10917444
OpenAlexW4391345064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.